Discover why so many are choosing KESIMPTA, and get insights from people who take it—sign up here to learn more.
QUESTIONS TO ASK YOUR DOCTOR
Choosing your RMS treatment? You can take an active role in this decision. Use this guide to get prepared with the right questions to ask your doctor.
ANDY M.
Dad, Account Executive, and Real Patient
Chose KESIMPTA as 1st treatment: 2022
HEAR WHAT PEOPLE ARE SAYING
"Between work and being a dad, I'm always busy. But KESIMPTA fit my life, plus had significant results—reducing relapses and slowing disability progression. That impressed me.‡"
Individual results may vary.
‡Reduced annual rate of relapses by 51% and 58%, reduced disability progression by 34% at 3 months and 32% at 6 months in 2 studies vs teriflunomide.
KARINA L.
Photographer, Music Festival Fan, and Real Patient
Chose KESIMPTA as 1st treatment: 2022
LEARN HOW TO TAKE KESIMPTA
"Giving myself a shot made me nervous. But once I tried the auto-injector pen, I felt like, yeah—I got this!"
Prescribed KESIMPTA?
96% of all prescriptions filled paid as little as $0 out of pocket cost when used with the Co-Pay Plus offer.§‖
Unless otherwise indicated, all people featured on this webpage are living with relapsing multiple sclerosis, have taken KESIMPTA, and have been compensated for their time.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
§Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. See complete Terms & Conditions at start.kesimpta.com.
‖2025 data on file.